Navigation Links
Recently FDA-Approved Full Neck Treatment for Sagging Skin Now Available at Maryland Laser Skin and Vein Institute
Date:12/28/2012

Baltimore, MD (PRWEB) December 28, 2012

Ultherapy non-surgical ultrasound treatments, which the physicians at the Maryland Laser, Skin and Vein Institute have been using for facial treatments, are now FDA-cleared for use to treat sagging skin on the neck and under the chin.

In a single treatment session, Ultherapy can tighten lax neck skin and improve firmness, all without any downtime. The Ulthera device uses sound waves targeted beneath the skin to gently heat, tighten and lift the skin, creating a younger, firmer look. And because Ulthera uses ultrasound, the surface skin is left undisturbed.

"We are excited to extend the range of Ultherapy treatments we offer to our patients for use on the neck,” says Dr. Weiss. “We’ve been having great results with Ulthera already on the face and already seeing improvements from application on the neck."

Based in Hunt Valley (Baltimore), MD, the MDLSV Institute not only treats thousands of patients per year, but is a leading clinical research facility investigating new skin treatments and devices for the purposes of FDA clearance and improving patient treatments and outcomes.

To schedule a consultation for treatment with Board Certified Dermatologists, please contact MDLSV (http://www.mdlsv.com)

Dr. Weiss, Director of the Maryland Laser Skin and Vein Institute, is one of America’s foremost dermatologists, and a past president of the American Society of Dermatologic Surgery. As an authority on dermatology, cosmetic dermatology and dermatologic surgery, laser medicine, and non-invasive body contouring, Dr. Weiss has been featured on national news programs such as 20/20 and The Today Show and is an author of multiple textbooks and textbook chapters on dermatology, lasers and cosmetic treatments such as botulinum toxin, fillers and spider veins.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10273304.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Recently Published Economic Analysis Highlights the Financial Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) in the United States (US)
2. Stemedica Issued U.S. Patent For Stem Cell Treatment of Diabetic Retinopathy and Diabetic Optic Neuropathy
3. Mold Linked With Fatal Asthma and Allergy Attacks; Dr Mold Network Suggests Use of Molderizer and Safe Shield for Safer Mold Treatment
4. Milo Biotechnology Announces FDA Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy
5. CureLauncher is Described on LIVESTRONG Blog as Modern Platform That Gets People Involved in Advancing New Cancer Treatments
6. Sandy Mold Extends Its Health Risks to Hired Cleaners; My Cleaning Products Says Complete Mold Treatment Gear and Molderizer are Needed to Stop Mold and Its Risks
7. NKT Therapeutics Presents Data on Potential Antibody Treatment for Sickle Cell Disease
8. A Sewage Treatment Plant Goes Underground Using In-Pipe Technology Company, Inc. Bioaugmentation
9. Caris Sponsors CancerCare Connect Education Workshop on Molecular Profiling in the Treatment of Breast Cancer
10. Only 16% of Donations go to New Cancer Treatments in Some Charities. With cureLauncher, 91% of Contributions Go Directly to New Cures for Cancer.
11. University of College London Hospitals (UCLH) Selects GEO SCAN Medical as New Standard of Care for the Detection and Treatment of Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , Feb. 22, 2017 Aethlon Medical, Inc. ... of a study that validated the ability of the ... associated with increased mortality in immune-suppressed sepsis patients and ... The objective of the study was to ... (CMV), Epstein-Barr virus (EBV) and Herpes Simplex virus 1 ...
(Date:2/22/2017)... N.C., Feb. 22, 2017  United Therapeutics Corporation (NASDAQ: ... results for the fourth quarter and year ended ... results reflect continued growth as net revenues reached ... Martine Rothblatt, Ph.D., United Therapeutics, Chairman and Chief ... to develop and advance our growing product pipeline, ...
(Date:2/21/2017)... ... February 21, 2017 , ... Vortex ... , a fully automated benchtop system for collecting intact circulating tumor cells (CTCs) ... at the Molecular Medicine Tri Conference (Tri-Con) Annual Meeting 2017 (February 19–24 San ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... Treximo will pair its $200M operational capacity with its strategic internal leadership ... in areas affecting quality and operational management. With office locations in ...
Breaking Biology Technology:
(Date:2/8/2017)... The biometrics market has reached a ... organizations, desires to better authenticate or identify users ... challenge questions), biometrics is quickly working its way ... is driven by use cases, though there traditionally ... uses cases, with consumer-facing use cases encompassing authentication, ...
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... , its innovative, highly flexible and award winning eClinical ... customers. iMedNet is a proven Software-as-a-Service (SaaS) ... Data Capture (EDC), but also delivers an entire suite ...
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
Breaking Biology News(10 mins):